Loading…
Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines
Recently, cell-based therapies have been explored as a strategy to enhance the specificity of anticancer therapeutic agents. In this perspective, human mesenchymal stromal cells (MSC) hold a promising future as cell delivery systems for anticancer proteins due to their unique biological features. In...
Saved in:
Published in: | Frontiers in cell and developmental biology 2020-07, Vol.8, p.471-471 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43 |
---|---|
cites | cdi_FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43 |
container_end_page | 471 |
container_issue | |
container_start_page | 471 |
container_title | Frontiers in cell and developmental biology |
container_volume | 8 |
creator | Silva, Marília Monteiro, Gabriel Amaro Fialho, Arsenio M. Bernardes, Nuno da Silva, Cláudia Lobato |
description | Recently, cell-based therapies have been explored as a strategy to enhance the specificity of anticancer therapeutic agents. In this perspective, human mesenchymal stromal cells (MSC) hold a promising future as cell delivery systems for anticancer proteins due to their unique biological features. In this study, we engineered human MSC to secrete a human codon-optimized version of azurin (hazu), a bacterial protein that has demonstrated anticancer activity toward different cancer models both
in vitro
and
in vivo
. To this end, microporation was used to deliver plasmid DNA encoding azurin into MSC derived from bone marrow (BM) and umbilical cord matrix (UCM), leading to expression and secretion of hazu to the conditioned medium (CM). Engineered hazu-MSC were shown to preserve tumor tropism toward breast (MCF-7) and lung (A549) cancer cell lines, comparable to non-modified MSC. Azurin was detected in the CM of transfected MSC and, upon treatment with hazu-MSC-CM, we observed a decrease in cancer cell proliferation, migration, and invasion, and an increase in cell death for both cancer cell lines. Moreover, expression of azurin caused no changes in MSC expression profile of cytokines relevant in the context of cancer progression, thus suggesting that the antitumoral effects induced by hazu-MSC secretome might be due to the presence of azurin independently. In conclusion, data shown herein indicate that MSC-produced azurin in a CM configuration elicits an anticancer effect. |
doi_str_mv | 10.3389/fcell.2020.00471 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8438a5c8ddb44c5595bc0e331720c28f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8438a5c8ddb44c5595bc0e331720c28f</doaj_id><sourcerecordid>2429780889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43</originalsourceid><addsrcrecordid>eNpVks1u1DAUhSMEolXpnqWXbDI4_ontDVIYWlppEAtAYmc5zs3UVWIPtlN1eA1eGM9MhejqWD5Hn6-uT1W9bfCKUqnejxamaUUwwSuMmWheVOeEqLZuKfv58r_zWXWZ0j3GuCFccElfV2eUiIIQ7Xn1Zx384LILHgb0BQa3zOg6hhl1v5fofH31uIuQkvNbdLPMxpdMAm_v9rOZ0LdckkXXZZCEPsEcfMrRZEio89nlZQ4RdTa7B5f3qNsaV3z0MYIpYvyANkvhro23EI8QtHEe0pvq1WimBJdPelH9uL76vr6pN18_3667TW0ZVbnuR6qIxFgpQRoGwDFXpmeWmdEqY9veEFBcAB1bzMG2pOnFIPuxaXFPxp7Ri-r2xB2Cude76GYT9zoYp48XIW61idnZCbRkVBpu5TD0jFnOFe8tBkobQbAlciysDyfWbulnGCz4sojpGfS5492d3oYHLWhLhcAF8O4JEMOvBVLWs0uHHzYewpI0YUQJiaVUJYpPURtDShHGf880WB-qoY_V0Idq6GM16F93469G</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2429780889</pqid></control><display><type>article</type><title>Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines</title><source>PubMed Central Free</source><creator>Silva, Marília ; Monteiro, Gabriel Amaro ; Fialho, Arsenio M. ; Bernardes, Nuno ; da Silva, Cláudia Lobato</creator><creatorcontrib>Silva, Marília ; Monteiro, Gabriel Amaro ; Fialho, Arsenio M. ; Bernardes, Nuno ; da Silva, Cláudia Lobato</creatorcontrib><description>Recently, cell-based therapies have been explored as a strategy to enhance the specificity of anticancer therapeutic agents. In this perspective, human mesenchymal stromal cells (MSC) hold a promising future as cell delivery systems for anticancer proteins due to their unique biological features. In this study, we engineered human MSC to secrete a human codon-optimized version of azurin (hazu), a bacterial protein that has demonstrated anticancer activity toward different cancer models both
in vitro
and
in vivo
. To this end, microporation was used to deliver plasmid DNA encoding azurin into MSC derived from bone marrow (BM) and umbilical cord matrix (UCM), leading to expression and secretion of hazu to the conditioned medium (CM). Engineered hazu-MSC were shown to preserve tumor tropism toward breast (MCF-7) and lung (A549) cancer cell lines, comparable to non-modified MSC. Azurin was detected in the CM of transfected MSC and, upon treatment with hazu-MSC-CM, we observed a decrease in cancer cell proliferation, migration, and invasion, and an increase in cell death for both cancer cell lines. Moreover, expression of azurin caused no changes in MSC expression profile of cytokines relevant in the context of cancer progression, thus suggesting that the antitumoral effects induced by hazu-MSC secretome might be due to the presence of azurin independently. In conclusion, data shown herein indicate that MSC-produced azurin in a CM configuration elicits an anticancer effect.</description><identifier>ISSN: 2296-634X</identifier><identifier>EISSN: 2296-634X</identifier><identifier>DOI: 10.3389/fcell.2020.00471</identifier><identifier>PMID: 32733876</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>azurin ; cancer ; Cell and Developmental Biology ; gene delivery ; mesenchymal stromal cells ; secretome</subject><ispartof>Frontiers in cell and developmental biology, 2020-07, Vol.8, p.471-471</ispartof><rights>Copyright © 2020 Silva, Monteiro, Fialho, Bernardes and da Silva. 2020 Silva, Monteiro, Fialho, Bernardes and da Silva</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43</citedby><cites>FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363770/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363770/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Silva, Marília</creatorcontrib><creatorcontrib>Monteiro, Gabriel Amaro</creatorcontrib><creatorcontrib>Fialho, Arsenio M.</creatorcontrib><creatorcontrib>Bernardes, Nuno</creatorcontrib><creatorcontrib>da Silva, Cláudia Lobato</creatorcontrib><title>Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines</title><title>Frontiers in cell and developmental biology</title><description>Recently, cell-based therapies have been explored as a strategy to enhance the specificity of anticancer therapeutic agents. In this perspective, human mesenchymal stromal cells (MSC) hold a promising future as cell delivery systems for anticancer proteins due to their unique biological features. In this study, we engineered human MSC to secrete a human codon-optimized version of azurin (hazu), a bacterial protein that has demonstrated anticancer activity toward different cancer models both
in vitro
and
in vivo
. To this end, microporation was used to deliver plasmid DNA encoding azurin into MSC derived from bone marrow (BM) and umbilical cord matrix (UCM), leading to expression and secretion of hazu to the conditioned medium (CM). Engineered hazu-MSC were shown to preserve tumor tropism toward breast (MCF-7) and lung (A549) cancer cell lines, comparable to non-modified MSC. Azurin was detected in the CM of transfected MSC and, upon treatment with hazu-MSC-CM, we observed a decrease in cancer cell proliferation, migration, and invasion, and an increase in cell death for both cancer cell lines. Moreover, expression of azurin caused no changes in MSC expression profile of cytokines relevant in the context of cancer progression, thus suggesting that the antitumoral effects induced by hazu-MSC secretome might be due to the presence of azurin independently. In conclusion, data shown herein indicate that MSC-produced azurin in a CM configuration elicits an anticancer effect.</description><subject>azurin</subject><subject>cancer</subject><subject>Cell and Developmental Biology</subject><subject>gene delivery</subject><subject>mesenchymal stromal cells</subject><subject>secretome</subject><issn>2296-634X</issn><issn>2296-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVks1u1DAUhSMEolXpnqWXbDI4_ontDVIYWlppEAtAYmc5zs3UVWIPtlN1eA1eGM9MhejqWD5Hn6-uT1W9bfCKUqnejxamaUUwwSuMmWheVOeEqLZuKfv58r_zWXWZ0j3GuCFccElfV2eUiIIQ7Xn1Zx384LILHgb0BQa3zOg6hhl1v5fofH31uIuQkvNbdLPMxpdMAm_v9rOZ0LdckkXXZZCEPsEcfMrRZEio89nlZQ4RdTa7B5f3qNsaV3z0MYIpYvyANkvhro23EI8QtHEe0pvq1WimBJdPelH9uL76vr6pN18_3667TW0ZVbnuR6qIxFgpQRoGwDFXpmeWmdEqY9veEFBcAB1bzMG2pOnFIPuxaXFPxp7Ri-r2xB2Cude76GYT9zoYp48XIW61idnZCbRkVBpu5TD0jFnOFe8tBkobQbAlciysDyfWbulnGCz4sojpGfS5492d3oYHLWhLhcAF8O4JEMOvBVLWs0uHHzYewpI0YUQJiaVUJYpPURtDShHGf880WB-qoY_V0Idq6GM16F93469G</recordid><startdate>20200709</startdate><enddate>20200709</enddate><creator>Silva, Marília</creator><creator>Monteiro, Gabriel Amaro</creator><creator>Fialho, Arsenio M.</creator><creator>Bernardes, Nuno</creator><creator>da Silva, Cláudia Lobato</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200709</creationdate><title>Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines</title><author>Silva, Marília ; Monteiro, Gabriel Amaro ; Fialho, Arsenio M. ; Bernardes, Nuno ; da Silva, Cláudia Lobato</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>azurin</topic><topic>cancer</topic><topic>Cell and Developmental Biology</topic><topic>gene delivery</topic><topic>mesenchymal stromal cells</topic><topic>secretome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silva, Marília</creatorcontrib><creatorcontrib>Monteiro, Gabriel Amaro</creatorcontrib><creatorcontrib>Fialho, Arsenio M.</creatorcontrib><creatorcontrib>Bernardes, Nuno</creatorcontrib><creatorcontrib>da Silva, Cláudia Lobato</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cell and developmental biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silva, Marília</au><au>Monteiro, Gabriel Amaro</au><au>Fialho, Arsenio M.</au><au>Bernardes, Nuno</au><au>da Silva, Cláudia Lobato</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines</atitle><jtitle>Frontiers in cell and developmental biology</jtitle><date>2020-07-09</date><risdate>2020</risdate><volume>8</volume><spage>471</spage><epage>471</epage><pages>471-471</pages><issn>2296-634X</issn><eissn>2296-634X</eissn><abstract>Recently, cell-based therapies have been explored as a strategy to enhance the specificity of anticancer therapeutic agents. In this perspective, human mesenchymal stromal cells (MSC) hold a promising future as cell delivery systems for anticancer proteins due to their unique biological features. In this study, we engineered human MSC to secrete a human codon-optimized version of azurin (hazu), a bacterial protein that has demonstrated anticancer activity toward different cancer models both
in vitro
and
in vivo
. To this end, microporation was used to deliver plasmid DNA encoding azurin into MSC derived from bone marrow (BM) and umbilical cord matrix (UCM), leading to expression and secretion of hazu to the conditioned medium (CM). Engineered hazu-MSC were shown to preserve tumor tropism toward breast (MCF-7) and lung (A549) cancer cell lines, comparable to non-modified MSC. Azurin was detected in the CM of transfected MSC and, upon treatment with hazu-MSC-CM, we observed a decrease in cancer cell proliferation, migration, and invasion, and an increase in cell death for both cancer cell lines. Moreover, expression of azurin caused no changes in MSC expression profile of cytokines relevant in the context of cancer progression, thus suggesting that the antitumoral effects induced by hazu-MSC secretome might be due to the presence of azurin independently. In conclusion, data shown herein indicate that MSC-produced azurin in a CM configuration elicits an anticancer effect.</abstract><pub>Frontiers Media S.A</pub><pmid>32733876</pmid><doi>10.3389/fcell.2020.00471</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2296-634X |
ispartof | Frontiers in cell and developmental biology, 2020-07, Vol.8, p.471-471 |
issn | 2296-634X 2296-634X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_8438a5c8ddb44c5595bc0e331720c28f |
source | PubMed Central Free |
subjects | azurin cancer Cell and Developmental Biology gene delivery mesenchymal stromal cells secretome |
title | Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T12%3A12%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conditioned%20Medium%20From%20Azurin-Expressing%20Human%20Mesenchymal%20Stromal%20Cells%20Demonstrates%20Antitumor%20Activity%20Against%20Breast%20and%20Lung%20Cancer%20Cell%20Lines&rft.jtitle=Frontiers%20in%20cell%20and%20developmental%20biology&rft.au=Silva,%20Mar%C3%ADlia&rft.date=2020-07-09&rft.volume=8&rft.spage=471&rft.epage=471&rft.pages=471-471&rft.issn=2296-634X&rft.eissn=2296-634X&rft_id=info:doi/10.3389/fcell.2020.00471&rft_dat=%3Cproquest_doaj_%3E2429780889%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2429780889&rft_id=info:pmid/32733876&rfr_iscdi=true |